Posts tagged CPXX


Company Update (NASDAQ:CPXX): Celator Pharmaceuticals Inc Announces Positive Results in Patients with FLT3 Mutation from the Phase 3 Trial

Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced positive response rate results in AML patients with FLT3 (FMS-like tyrosine …

Stock Update (NASDAQ:CPXX): Celator Pharmaceuticals Inc Cancels Analyst and Investor Meeting and Postpones Annual Meeting of Stockholders

Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced that it is cancelling its Analyst and Investor meeting scheduled for …

Analysts Downgrade Two Volatile Healthcare Stocks: Celator Pharmaceuticals Inc (CPXX), StemCells Inc (STEM)

Healthcare analysts are weighing in today on leukemia drug maker Celator Pharmaceuticals Inc (NASDAQ:CPXX) and biotechnology company StemCells Inc …

Analysts Chime In On Two Rising Biotech Stocks: Celator Pharmaceuticals Inc (CPXX), Spark Therapeutics Inc (ONCE)

Celator Pharmaceuticals Inc Roth Capital analyst Joseph Pantginis weighs in today on Celator Pharmaceuticals Inc (NASDAQ:CPXX), after the …

Stock Update (NASDAQ:CPXX): Celator Pharmaceuticals Inc Announces VYXEOS™ Granted Breakthrough Therapy Designation

Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced that the United States Food and Drug Administration (FDA) granted Breakthrough …

Stock Update (NASDAQ:CPXX): Celator Pharmaceuticals Inc Announces First Quarter 2016 Financial Results and Business Update

Celator Pharmaceuticals Inc (NASDAQ:CPXX) reported business highlights and financial results for the first quarter ended March 31, …

Company Update (NASDAQ:CPXX): Celator Pharmaceuticals Inc Announces New Data for VYXEOS™ to be Presented at the American Association for Cancer Research Annual Meeting

Celator Pharmaceuticals Inc (NASDAQ:CPXX) announced that data for VYXEOS™ (cytarabine:daunorubicin) Liposome for Injection (also known as …